Fractyl Health, Inc. (GUTS) has disclosed a new risk, in the Regulation category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fractyl Health, Inc. operates under stringent U.S. and foreign anti-corruption, export, and sanctions regimes, exposing it to significant compliance risk. Any violation by its employees or third-party partners could trigger severe civil and criminal penalties, operational restrictions, and lasting reputational damage that may adversely affect its growth and financial performance.
The average GUTS stock price target is $6.00, implying 1,100.00% upside potential.
To learn more about Fractyl Health, Inc.’s risk factors, click here.